Masaru Oba 研究室

AI 要約（直近 5 年の研究成果）

※ AI（Claude）が、公開されている論文要旨から研究の問い・手法・主要な発見を事実情報として抽出・再構成して自動生成しています。誤りを含む可能性があるため、正確性は研究室公式情報でご確認ください。

研究成果（6 件）

• [2024] Feasibility of major hepatectomy following preoperative chemotherapy for advanced perihilar cholangiocarcinoma
  DOI: https://doi.org/10.1016/j.ejso.2024.108733
• [2022] Sequential therapy of portal vein embolization and systemic chemotherapy for locally advanced perihilar biliary tract cancer
  DOI: https://doi.org/10.1016/j.ejso.2022.08.035
• [2022] A randomized controlled trial of surgery and postoperative modified FOLFOX6 versus surgery and perioperative modified FOLFOX6 plus cetuximab in patients with KRAS wild-type resectable colorectal liver metastases: EXPERT study
  DOI: https://doi.org/10.1007/s00423-022-02434-7
• [2022] A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial
  DOI: https://doi.org/10.1016/j.hpb.2022.02.001
• [2022] A multicenter phase II trial to assess the efficacy and safety of bevacizumab plus mFOLFOX6 as induction chemotherapy toward R0 surgical resection in advanced colorectal liver metastases with mutant-type KRAS: NEXTO-mt trial.
  DOI: https://doi.org/10.1200/jco.2022.40.4_suppl.450
• [2021] Adjuvant chemotherapy can prolong recurrence-free survival but did not influence the type of recurrence or subsequent treatment in patients with colorectal liver metastases
  DOI: https://doi.org/10.1016/j.surg.2021.04.012

科研費（0 件）

まだデータがありません（KAKEN 取り込み後に表示）。

所属学会・役職（0 件）

まだデータがありません（学会データ連携後に表示）。